Skip to main content
. 2017 Oct 10;16:126. doi: 10.1186/s12933-017-0609-4

Table 4.

Characteristics, risk factors, and diagnostic and therapeutic procedures for aortic aneurysm and dissection admissions in type 2 diabetes mellitus (T2DM) versus non-diabetic patients, according to year of study (2002, 2006, 2010, and 2014)

2002 2006 2010 2014
T2DM No T2DM p value T2DM No T2DM p value T2DM No T2DM p value T2DM No T2DM p value
N (%)a,b 390 (100) 390 (100) NA 615 (100) 615 (100) NA 753 (100) 753 (100) NA 841 (100) 841 (100) NA
Age adjusted rate per 100.000 inhabitants 2.03 NA NA 2.93 NA NA 3.3 NA NA 3.45 NA NA
Male sex, n (%) 364 (93.33) 364 (93.33) NA 591 (96.1) 591 (96.1) NA 710 (94.29) 710 (94.29) NA 802 (95.36) 802 (95.36) NA
Age, mean (SD)a,b 69.84 (9.03) 69.84 (9.03) NA 71.06 (8.12) 71.06 (8.12) NA 71.43 (8.08) 71.43 (8.08) NA 72.41 (7.85) 72.41 (7.85) NA
40–59 years, n (%) 56 (14.36) 56 (14.36) NA 60 (9.76) 60 (9.76) NA 55 (7.3) 55 (7.3) NA 51 (6.06) 51 (6.06) NA
60–69 years, n (%) 106 (27.18) 106 (27.18) 177 (28.78) 177 (28.78) 234 (31.08) 234 (31.08) 247 (29.37) 247 (29.37)
70–79 years, n (%) 184 (47.18) 184 (47.18) 288 (46.83) 288 (46.83) 350 (46.48) 350 (46.48) 376 (44.71) 376 (44.71)
≥ 80 years, n (%) 44 (11.28) 44 (11.28) 90 (14.63) 90 (14.63) 114 (15.14) 114 (15.14) 167 (19.86) 167 (19.86)
CCI, mean (SD)a,b 2.48 (0.82) 1.42 (0.82) < 0.01 2.56 (0.84) 1.49 (0.79) < 0.01 2.59 (0.76) 1.53 (0.79) < 0.01 2.7 (0.84) 1.59 (0.75) < 0.01
Smoking, n (%)a,b 139 (35.64) 136 (34.87) 0.802 238 (38.7) 214 (34.8) 0.145 323 (42.9) 316 (41.97) 0.702 363 (43.16) 360 (42.81) 0.879
Obesity, n (%)a,b 19 (4.87) 11 (2.82) 0.149 32 (5.2) 20 (3.25) 0.099 79 (10.49) 28 (3.72) < 0.01 82 (9.75) 45 (5.35) 0.001
Hypertension, n (%)a,b 213 (54.62) 139 (35.64) < 0.01 367 (59.67) 269 (43.74) < 0.01 470 (62.42) 371 (49.27) < 0.01 541 (64.33) 430 (51.13) < 0.01
Lipid metabolism disorders, n (%)a,b 47 (12.05) 20 (5.13) 0.001 129 (20.98) 83 (13.5) 0.001 292 (38.78) 200 (26.56) < 0.01 427 (50.77) 292 (34.72) < 0.01
Renal diseases, n (%)a,b 31 (7.95) 28 (7.18) 0.686 67 (10.89) 62 (10.08) 0.635 114 (15.14) 84 (11.16) 0.021 147 (17.48) 118 (14.03) 0.053
Atrial fibrillation, n (%)a,b 38 (9.74) 26 (6.67) 0.112 58 (9.43) 67 (10.89) 0.376 90 (11.95) 106 (14.08) 0.212 157 (18.67) 116 (13.79) 0.007
CHF, n (%) 22 (5.64) 13 (3.33) 0.100 29 (4.72) 24 (3.9) 0.493 44 (5.84) 40 (5.31) 0.638 41 (4.88) 34 (4.04) 0.407
Mechanical ventilation, n (%) 36 (9.23) 32 (8.21) 0.593 55 (8.94) 48 (7.8) 0.483 36 (4.78) 60 (7.97) 0.009 61 (7.25) 62 (7.37) 0.919
HD/DP, n (%) 7 (1.79) 5 (1.28) 0.566 18 (2.93) 14 (2.28) 0.467 16 (2.12) 23 (3.05) 0.240 25 (2.97) 24 (2.85) 0.884
Thoracic aorta aneurysm open surgery, n (%)a,b 9 (2.31) 9 (2.31) 0.903 22 (3.58) 30 (4.88) 0.198 25 (3.32) 46 (6.11) 0.005 43 (5.11) 50 (5.95) 0.379
TEVAR, n (%) 0 (0) 0 (0) NA 0 (0) 0 (0) NA 25 (3.32) 16 (2.12) 0.133 37 (4.4) 32 (3.8) 0.508
Abdominal aorta aneurysm open surgery, n (%)a,b 86 (22.05) 94 (24.1) 0.454 111 (18.05) 112 (18.21) 0.940 100 (13.28) 128 (17) 0.038 137 (16.29) 153 (18.19) 0.281
EVAR, n (%)a,b 19 (4.87) 22 (5.64) 0.640 93 (15.12) 76 (12.36) 0.139 232 (30.81) 190 (25.23) 0.013 312 (37.1) 291 (34.6) 0.250
LHS, mean (SD)a,b 15.63 (16.07) 12.88 (12.95) 0.008 11.82 (12.11) 11.44 (16.71) 0.644 11.28 (18.3) 10.92 (13.32) 0.669 9.43 (13.33) 9.63 (13.24) 0.760
In-hospital mortality, n (%)a 56 (14.36) 50 (12.82) 0.447 77 (12.52) 78 (12.68) 0.920 82 (10.89) 90 (11.95) 0.446 68 (8.09) 84 (9.99) 0.118

CCI charlson comorbidity index, CHF congestive heart failure, HD/DP hemodyalisis/peritoneal dialysis, TEVAR endovascular implantation of graft in thoracic aorta, EVAR endovascular implantation of graft in abdominal aorta, LHS length of hospital stay

aSignificant time trend among T2DM sufferers

bSignificant time trend among non-T2DM sufferers